beta-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

Sturm G. J., Herzog S. A., Aberer W., Alfaya Arias T., Antolin-Amerigo D., Bonadonna P., ...Daha Fazla

ALLERGY, cilt.76, sa.7, ss.2166-2176, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 76 Sayı: 7
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1111/all.14785
  • Dergi Adı: ALLERGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.2166-2176
  • Anahtar Kelimeler: ACE inhibitor, adverse event, beta-blocker, systemic insect sting reaction, venom immunotherapy
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background There is controversy whether taking beta-blockers or ACE inhibitors (ACEI) is a risk factor for more severe systemic insect sting reactions (SSR) and whether it increases the number or severity of adverse events (AE) during venom immunotherapy (VIT).